Announcements Trials
Browse Landscape

Phase

Phase NA 54Phase 2 3Phase 3 2Phase 2/3 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Breast 2Tumor-Agnostic 1Other 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Lymphedema 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 171Docetaxel 163Paclitaxel 160Trastuzumab 151Capecitabine 130Tamoxifen 119Letrozole 105Epirubicin 93Doxorubicin 83Anastrozole 83exemestane 77Fulvestrant 75Carboplatin 64Fluorouracil 63Radiotherapy 61pertuzumab 59Gemcitabine 55Vinorelbine 43Goserelin 39eribulin 36130-nm albumin-bound paclitaxel 36palbociclib 32Bevacizumab 32ribociclib 30Zoledronic Acid 29Lapatinib 29Methotrexate 28Drug Therapy 28Chemotherapy, Adjuvant 28Ado-Trastuzumab Emtansine 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Methods × Breast × Clear all
NCT00376597 2026-05-18

Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection

Alliance for Clinical Trials in Oncology

Phase 3 Completed
568 enrolled 7 charts
Breast

Breast Neoplasms, Lymphedema

NCT06763328 2026-01-22

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

City of Hope Medical Center

Phase 3 Recruiting
200 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡